🇦🇺 Australia Country × Condition
obesity Clinical Trials in Australia
Active clinical trials for obesity with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT07503210 Phase 3
Recruiting
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Enrollment
600 pts
Country
🇦🇺 Australia
Novo Nordisk A/S
View Trial → NCT07481630 Phase 3
Recruiting
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Enrollment
400 pts
Country
🇦🇺 Australia
Novo Nordisk A/S
View Trial → NCT07253285 Phase 3
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Enrollment
460 pts
Country
🇦🇺 Australia
Novo Nordisk A/S
View Trial → NCT07321886 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Enrollment
1,980 pts
Country
🇦🇺 Australia
Eli Lilly and Company
View Trial → Frequently Asked Questions
How many obesity clinical trials are active in Australia?
There are currently 4 active clinical trials for obesity with sites in Australia, of which 4 are actively recruiting patients.
How can I join a obesity clinical trial in Australia?
To join a obesity clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are obesity trials in Australia?
Active obesity trials in Australia span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology